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Abstract
Background: Accurate estimates of hypertension prevalence are critical for assessment of population health and
for planning and implementing prevention and health care programs. While self-reported data is often more
economically feasible and readily available compared to clinically measured HBP, these reports may underestimate
clinical prevalence to varying degrees. Understanding the accuracy of self-reported data and developing prediction
models that correct for underreporting of hypertension in self-reported data can be critical tools in the
development of more accurate population level estimates, and in planning population-based interventions to
reduce the risk of, or more effectively treat, hypertension. This study examines the accuracy of self-reported survey
data in describing prevalence of clinically measured hypertension in two racially and ethnically diverse urban
samples, and evaluates a mechanism to correct self-reported data in order to more accurately reflect clinical
hypertension prevalence.
Methods: We analyze data from the Detroit Healthy Environments Partnership (HEP) Survey conducted in 2002 and
the National Health and Nutrition Examination (NHANES) 2001–2002 restricted to urban areas and participants
25 years and older. We re-calibrate measures of agreement within the HEP sample drawing upon parameter
estimates derived from the NHANES urban sample, and assess the quality of the adjustment proposed within
the HEP sample.
Results: Both self-reported and clinically assessed prevalence of hypertension were higher in the HEP sample
(29.7 and 40.1, respectively) compared to the NHANES urban sample (25.7 and 33.8, respectively). In both urban
samples, self-reported and clinically assessed prevalence is higher than that reported in the full NHANES sample in
the same year (22.9 and 30.4, respectively). Sensitivity, specificity and accuracy between clinical and self-reported
hypertension prevalence were ‘moderate to good’ within the HEP sample and ‘good to excellent’ within the
NHANES sample. Agreement between clinical and self-reported hypertension prevalence was ‘moderate to good’
within the HEP sample (kappa =0.65; 95% CI = 0.63-0.67), and ‘good to excellent’ within the NHANES sample
(kappa = 0.75; 95%CI = 0.73-0.80). Application of a ‘correction’ rule based on prediction models for clinical
hypertension using the national sample (NHANES) allowed us to re-calibrate sensitivity and specificity estimates for
the HEP sample. The adjusted estimates of hypertension in the HEP sample based on two different correction
models, 38.1% and 40.5%, were much closer to the observed hypertension prevalence of 40.1%.
Conclusions: Application of a simple prediction model derived from national NHANES data to self-reported data
from the HEP (Detroit based) sample resulted in estimates that more closely approximated clinically measured
hypertension prevalence in this urban community. Similar correction models may be useful in obtaining more
accurate estimates of hypertension prevalence in other studies that rely on self-reported hypertension.
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Background
Hypertension affects an estimated 30% [1-3] of the popu-
lation in the United States, and is associated with health
outcomes such as cardiovascular disease, heart attack and
stroke [4-8]. Population estimates of hypertension preva-
lence are often assessed through large scale surveys which
rely on participant self reports of previous clinical diagno-
sis of hypertension [5,9]. Self-reported data is often more
economically feasible and readily available (e.g., through
telephone interviews [10,11]) compared to clinically mea-
sured high blood pressure (HBP). However, given substan-
tial evidence that awareness of hypertension is imperfect
(for example, discrepancies between clinical measures and
self-reported hypertension), reliance on self-reported data
may contribute to inaccuracies in estimating population
prevalence of hypertension [12-15]. Furthermore, given
evidence that awareness varies across various subgroups
within the United States [16-19], reliance on self-reported
data to estimate prevalence in small areas where popula-
tion characteristics differ from national characteristics may
contribute to inaccuracies in prevalence estimates.
Several studies have examined the validity of self-
reported hypertension and its use for surveillance of
hypertension trends. Studies using national data such as
NHANES [18,20] or large samples [11,21,22] have sug-
gested that self-reported data may underestimate hyper-
tension prevalence [10,12-15], given that some with
hypertension are unaware or otherwise do not report the
condition [5,16,23]. Age, gender, education, geographic
area, marital status, race and ethnicity have been found to
be associated with accuracy of self-reported HBP
[4,6,7,16,24-27]. Studies that have attempted to gauge the
extent of this problem have reported differences between
clinically measured and self-reported HBP that range from
2.0 [5] to 27.0% [16]. Most studies designed to assess the
accuracy of self-report data have compared self-reported
high blood pressure to a ‘gold standard’ [17,23,28-31] such
as measurements obtained from physical examinations
using a mercury sphygmomanometer [26,32]. The major-
ity of these studies have been based on small samples;
have relied on volunteers; include only persons in good
health; or recruit participants of particular organizations
(e.g., an HMO) or screening programs. These factors limit
the ability to either generalize to broader populations or
identify characteristics that may be associated with differ-
ential accuracy of the self-reported versus clinically mea-
sured HBP. One validation study has been based on a
nationally representative sample [33], and this study iden-
tified a prediction model used to estimate prevalence of
high blood pressure. These methods were developed for
large-scale national samples, and require fairly sophisti-
cated statistical expertise to implement.
However, there are well-established differences in the
rates, awareness and treatment of hypertension across
racial and ethnic groups, by socioeconomic status, and
across geographical areas within the United States
[25,34]. Thus, the applicability of national models within
specific communities or areas may vary. In addition, the
severity of the underestimation of self-reported data var-
ies across different chronic diseases [16,23] such as dia-
betes, stroke and heart attacks [11,35-38]. Assessing the
validity of self-reported data in estimating hypertension
prevalence in specific geographic areas, and developing
simple prediction models that correct for possible miss
reporting of HBP in self-reported data, can be essential
to the creation of accurate population level estimates,
and for population level efforts to effectively prevent or
treat HBP within particular contexts. To date, no studies
of which we are aware have developed such a correction
model for self-reported data at local geographic levels.
Thus, our objective in this paper is to examine the ac-
curacy of self-reported data in describing the prevalence
of hypertension in racially and ethnically diverse urban
community, and to develop a simple tool to correct self-
reported data to more accurately reflect clinical preva-
lence of HBP. Specifically, we aim to:
Aim1: Examine the extent to which reliance on
self-reported data may miss-characterize
hypertension prevalence in a multiethnic
urban community.
Aim2: Develop a prediction model to calibrate
self-reported data to more closely correspond
to the clinical prevalence of hypertension in a
local community sample.
To address these aims, we draw on data from two
multiethnic urban samples, the 2002 Healthy Environ-
ments Partnership (HEP) community survey [39] and
the NHANES 2001–2002 national survey, restricted to
residents 25 years and older of metropolitan areas as
described in the following section.
Methods
Sample and data collection
Data for this study are drawn from two sources: 1) the
Healthy Environment Partnership (HEP) community
survey conducted in 2002 with adults aged 25 and older
living in three areas of Detroit, Michigan; and 2) the
NHANES 2001–2002 data, restricted to the subset of
the sample collected in urban metropolitan Careas, and
25 years of age and older, in order to match the HEP
sample.
The HEP survey is a two-stage probability sample of
occupied housing units (households), designed for 1,000
completed interviews of adults, age 25 years and older.
The complex design features allow for comparisons of
residents of similar demographics across geographic
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areas of the city. The final study sample consisted of 919
valid face-to-face interviews completed in 2002. Inter-
views were completed with 75% of households in which
an eligible respondent was identified [39]. Data was col-
lected included self-reported demographic variables, psy-
chosocial, behavioral, and socioeconomic indicators, and
both self-reported and clinically measured BP.
The NHANES 2001–2002 sample is a nationwide
probability sample of the population selected via a com-
plex series of statistical techniques (for references on the
design of the NHANES sample refer to http://www.cdc.
gov/nchs/nhanes/about_nhanes.htm). For this study we
restrict the NHANES 2001–2002 sample to include
cases that have clinical measured hypertension (n=4878).
For this sample to closely match the HEP sample we lim-
ited the national sample to include only urban metropol-
itan areas and individuals 25 years old and older (n=1114).
We refer to this sample henceforth as the NHANES urban
sample.
Measures
Dependent variables
The dependent variable for this study was high blood
pressure (HBP), and we included both self-report and
clinically measured indicators within each sample.
Self-reported high blood pressure status (SR) in both
HEP and the NHANES studies, was determined based
on the response to the question “Has a doctor or other
health provider ever told you that you had hypertension,
also called high blood pressure?” Individuals who
responded “yes” to this question were coded as having
self-reported high blood pressure.
Clinically measured high blood pressure, (CH) was
constructed as follows, for both the HEP and the
NHANES survey data. Three measures of systolic and
diastolic blood pressure were obtained using a portable
cuff device (Omron model HEM 711 AC) that passed
Association for the Advancement of Medical Instrumen-
tation standards [40]. In both the mean of the second
and third reading were calculated for systolic and dia-
stolic blood pressure readings. CH was defined as mean
systolic blood pressure > 140 and/or mean diastolic
blood pressure >90 and/or self-report of current treat-
ment with antihypertensive medication.
Independent variables
Independent variables included in the prediction models
were derived from survey data and included age in years;
gender (ref: female); marital status (ref: married); annual
household income categorized into four levels: less than
$10 K, $10 K-$19 K, $20 K-$34 K and $35 K or more
(ref ); and education categorized into three levels: less
than 12 years of education, completed high school and
more than 12 years of education (ref ); self-reported race
and ethnicity, categorized as Hispanic, non-Hispanic
White and non-Hispanic Black (ref ). Non-Hispanic
Black was chosen as the reference group because it’s the
largest group size for the HEP sample, and affords the
most robust standard errors for the re-calibration step of
the process.
Statistical analysis
The statistical analysis for this paper has two distinct
parts, each one corresponding to one of the two aims of
the paper described in the previous section: Aim 1) As-
sessment of concordance between self-reported and clin-
ically measures HBP was performed for both samples
(HEP and NHANES urban samples); Aim 2) Calibration
of measures of agreement within the HEP sample
drawing upon parameter estimates derived from the
NHANES urban sample.
Assessment of validity and concordance between self-
reported and clinically measures HBP (Aim 1)
Statistical measures of 1) sensitivity (percent fitting the
medical criteria for hypertension who reported that they
had the condition); 2) specificity (percent not fitting the
medical criteria who reported they do not have the con-
dition); 3) accuracy or overall level of agreement (percent
for whom the medical criteria and self-reported are in
agreement); and 4) Cohen’s Kappa coefficient with ad-
justment for chance agreement were used to assess the
validity and concordance between of self-reported and
clinical measure hypertension within each urban sample
(HEP and NHANES urban).
Each statistical measure was calculated for the full
sample, and also stratified by each of the independent
variables considered for this analysis (e.g. age, gender,
race and ethnicity, education and household income).
Calibration of sensitivity and specificity within the HEP
sample drawing upon parameter estimates derived from
the NHANES urban sample (Aim 2)
Our objective is to develop a simple prediction model to
calibrate self-reported data to more closely correspond
to the clinical prevalence of hypertension in a local com-
munity sample. To do so we drew form the NHANES
urban sample described above. The NHANES urban
sample was stratified by whether a participant reported
having ever been told by a doctor that they had HBP,
with “yes” coded as SR = 1 and “no” coded as SR= 0,
respectively. We then fitted weighted logistic regression
models within each strata using IVEWare %Regress
procedure (SAS Windows 9.2) to predict each indivi-
dual’s probability of having clinically measured HBP
adjusting for age, gender, marital status, race and ethni-
city, indicators of annual household income, and
education.
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The parameter estimates from these two logistic mod-
els were then applied (‘plug-in method’) to the HEP
sample to obtain re-calibrated estimates of sensitivity
and specificity for the HEP sample, for each participant
as follows:
specify ¼ 1 P^ CHi ¼ 1jSRi ¼ 0;Xið Þ ¼ 1
exp Xiβ^o
 
1þ exp Xiβ^o
  ð1Þ
sensitivity ¼ P^ CHi ¼ 1jSRi ¼ 1;Xið Þ ¼
exp Xiβ^1
 
1þ exp Xi β^1
 
ð2Þ
Where β^o and β^1 are the vectors of point estimates
from the two logistic models fitted within each of the
strata of the NHANES urban sample, SR =1 (been told
they have HBP) or SR = 0 (never told have HBP).
We considered two approaches to obtain estimates of
the probability of clinically measured HBP within the
HEP dataset. These are described below as Method 1
and 2.
Method 1:
a) For individuals who reported never being told they
had HBP (SR = 0), we estimate the probability of
having clinically measured HBP using one minus the
specificity estimate described in Equation (1).
b) For individuals who reported having been told they
had HBP (SR = 1), we estimate the probability of
having clinically measured HBP using the sensitivity
estimate described in Equation (2).
Method 2: This alternate method is relevant when one
wants to estimate marginal prevalence of clinically mea-
sured HBP for individuals by weighting Method 1 esti-
mates with estimated probability of self-reported HBP.
This method may be sought if self-reported data is not
Table 1 HEP and NHANES demographic measures
HEP1 NHANES2
(N= 919) (N= 1114)
Age, mean (stddev3) 46.3(0.8) 48.2(0.4)
Age, % 25-34 46.1 46.3
35-49 33.6 34.4
50+ 20.3 19.3
Gender, % Female 52.3 52.1
Marital Status, % Married 26.4 62.4
Race/Ethnicity, % Latino 22.2 12.3
non-Hispanic White 18.8 72.7
non-Hispanic Black 56.8 10.5
Other 2.3 4.5
Education, % <12 years 37.3 19.0
12 years 29.5 25.0
>12 years 33.2 56.0
Annual Household
Income4, %
<$10,000 27.3 18.3
$10,000-19,999 26.0 15.5
$20,000-34,999 23.6 21.6
$35,000+ 23.0 44.6
Number of members
in HU, mean(stddev)
2.8(0.1) 3.7(0.1)
1: Healthy Environments Partnership.
2: National Health and Examination Survey restricted age 25+ and Urban.
3: Stddev = Standard deviation.
Table 2 Prevalence of self-reported and clinically
measured HBP by levels of the covariates included in the
prediction models (HEP1 sample)
N HBP2 Prevalences Difference3
Clinical Self-reported
Overall 919 40.1 29.7 10.4
Age
25-34 242 15.6 8.2 7.4
35-49 342 34.3 23.3 11.0
50+ 335 64.8 52.5 12.3
Gender
Female 632 39.2 31.9 7.3
Male 287 41.1 27.2 13.9
Marital Status
Current Married 230 38.3 27.5 10.8
Not Married 689 49.5 37.8 11.7
Race/ethnicity
Latino 182 26.6 16.0 10.6
non-Hispanic White 199 41.2 27.3 13.9
non-Hispanic Black 522 46.0 36.3 9.7
Education
<12 327 43.5 31.4 12.1
12 259 38.3 28.9 9.4
12+ 321 37.8 28.8 9.0
Annual Household Income
<$10,000 250 47.7 40.4 7.3
$10,000-19,999 238 39.4 29.7 9.7
$20,000-34,999 230 37.3 23.7 13.6
$35,000+ 201 34.7 22.8 11.9
1: Healthy Environments Partnership.
2: Hypertensive if mean systolic BP= >140 or mean diastolic BP= > 90 or
currently taking hypertensive medication.
3: Difference between clinical and self-reported hypertension.
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complete or reliable and one wants to impute/replace it
by using covariate information.
a) Estimates of the probability of self-reported HBP
within the HEP sample, using weighted logistic
regression models adjusting for the same set of
covariates used to develop the prediction model
described in Method 1.
P^ CHi ¼ 1 SRi;Xij Þð ð3Þ
b) Estimate of the probability of clinically measured
HBP as a weighted average of re-calibrated sensitivity
and specificity as follows:
P^ CHi ¼ 1jXið Þ ¼ P^ CHi ¼ 1jSRi ¼ 0;Xið Þ
 P^ SRi ¼ 0jXið Þ þ P^ CHi ¼ 1jSRi ¼ 1;Xið Þ
 P^ SRi ¼ 1jXið Þ ð4Þ
where P^ SRi ¼ 0jXið Þ ¼ 1 P^ SRi ¼ 1jXið Þ
Finally, we then considered 0.50, 0.60, 0.70 and 0.80 as
threshold values of the estimated probability of clinically
measured HBP which were used to classify each individ-
ual into one of two groups: HBP according to clinical
measures or not (binary representation of predicted
probabilities based on both proposed methods). That
is if,
P^ CHi ¼ 1jXið Þ > threshold; ð5Þ
we classify the HEP participant as having predicted clin-
ically HBP, i.e.,
C^H i ¼ 1; ð6Þ
otherwise we classify him/her as not having predicted
clinically HBP. For each proposed threshold misclassifi-
cation rates were assessed using measures of
Sensitivity ¼ P C^H ¼ 1 CH ¼ 1j Þ; ð7Þ
Table 3 Sensitivity, specificity and agreement indicators for each determinant investigated (age, gender, marital
status, educational level, income level)
Sensitivity Specificity Accuracy1 Kappa
P(CH=1|SR= 1) P(CH=0|SR= 0) (overall agreement)
Full sample 0.90 0.80 0.83 0.66
Age
25-34 0.71 0.88 0.85 0.64
35-49 0.86 0.81 0.82 0.57
50+ 0.95 0.69 0.83 0.83
Gender
Females 0.88 0.83 0.85 0.66
Males 0.9 0.8 0.8 0.59
Marital Status
Currently Married 0.90 0.82 0.84 0.65
Not Married 0.89 0.80 0.83 0.65
Race/ethnicity
Latino 0.89 0.85 0.86 0.65
non-Hispanic White 0.90 0.77 0.81 0.65
non-Hispanic Black 0.90 0.79 0.83 0.66
Education
<12 0.92 0.79 0.83 0.65
12 0.79 0.82 0.81 0.65
12+ 0.86 0.82 0.83 0.66
Annual Household Income
<$10,000 0.77 0.83 0.81 0.66
$10,000-19,999 0.92 0.83 0.86 0.65
$20,000-34,999 0.89 0.79 0.81 0.65
$35,000+ 0.97 0.77 0.83 0.66
Accuracy is the proportion of true results (both true positive and true negative). Refer to Additional file 1.
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and
Specificty ¼ 1 P C^H ¼ 1 CH ¼ 0j Þ; ð8Þ
where C^H and CH are predicted and known clinically
measured HBP within the HEP sample respectively,
using weighted cross-classification techniques. The
threshold value with lowest miss-classification rate was
proposed for final classification.
Results
As shown in Table 1, the average age of HEP community
survey participants was 46.3±0.8 years, 52.3% were fe-
male, 56.8% non-Hispanic Black, 22.6% Hispanic (of this
group, 75.8% identified as Mexican American); 37.3%
had less than 12 years of education, 27.3% had house-
hold incomes less than $10,000, 26.4% were married,
and the mean number of household members was 2.8.
For the NHANES urban sample the average age was
48.2±0.4 years, 52.1% were female, 10.5% were non-
Hispanic Black; 12.3% Hispanic (with 84.7% of this
group identified as Mexican American), 19.0% had less
than 12 years of education, 18.3% had household
incomes less than $10,000, 62.4% were married, and the
mean number of household members was 3.7.
Prevalence of hypertension based on self-reported data
underestimates the clinical prevalence by 10.4% for the
full HEP sample (Table 2). When we consider prevalence
estimates for different demographics indicators such as
age (continuous and categorical), gender, race and ethni-
city, education and annual household income, underesti-
mates range from 7.3% to 13.9%. In particular, the
largest percent of under-reporting were observed for
non-Hispanic Whites (13.9%) and for those with annual
household income between $20 K-$34 K (13.6%).
Sensitivity, specificity, accuracy (overall agreement)
and Kappa statistics of the self-reported measure of HBP
for the full HEP sample and stratified by each investi-
gated determinant are shown in Table 3. These results
show that self-reported and clinical measure hyperten-
sion for the HEP sample have generally ‘moderate to
good’ agreement: sensitivity (range = 0.77-0.97); specifi-
city (range = 0.77-0.83); accuracy (range = 0.81-0.83); and
overall Kappa ( range = 0.65-0.66). Comparing Tables 2
and 3, we conclude that the use of self-reported data has
“good” validity, and is likely to underestimate population
based hypertension prevalence within the HEP sample.
Tables 4 and 5 show that the under- reporting of
hypertension using self-reported data in the NHANES
national urban sample is generally smaller than in the
HEP sample (range = 6.1%-11.5%). Within this sample,
validity and concordance are generally in the ‘good to
excellent’ range: sensitivity(range = 0.89-0.99); specificity
(range = 0.82-0.89); accuracy (range = 0.86-0.90); and
overall Kappa ( range = 0.75-0.77). Thus, we propose the
use of the national urban sample to develop the predic-
tion models described in Aim 2.
In order to avoid overestimation of prediction models,
sample sizes should be at least 15–30 per predictor
[41-43]. Stratified sample sizes within the NHANES
urban sample were insufficient to meet this threshold,
and therefore would have compromised the stability of
the prediction model. Thus, we used the full NHANES
urban sample to develop the prediction model.
In Table 6, we show parameter estimates based on
weighted logistic models for predicting clinically mea-
sured HBP from self-reported HBP, using the NHANES
urban sample. Results are shown stratified by the self-
report indicator, that is, with separate models and par-
ameter estimates for those who reported having been
told, versus never having been told by a health care
Table 4 Prevalence of self-reported and clinically
measured HBP by levels of the covariates included in the
prediction models (NHANES1 urban sample)
N NHANES2 Prevalences Difference3
Clinical Self-reported
Overall 1124 33.8 25.7 8.1
Age
25-34 172 37.4 30.6 6.8
35-49 256 61.1 54.7 6.4
50+ 169 67.0 51.5 15.5
Gender
Females 583 34.3 28.2 6.1
Males 541 33.2 22.9 10.3
Marital Status
Current Married 692 31.6 23.3 8.3
Not Married 432 37.9 30.1
Race/ethnicity
Latino 261 21.1 10.8 10.3
non-Hispanic White 614 35.8 27.7 8.1
non-Hispanic Black 215 40.3 31.1 9.2
Education
<12 366 45.5 36.4 9.1
12 251 36.7 27.7 9.0
12+ 502 28.2 20.9 7.3
Annual Household Income
<$10,000 166 46.9 35.4 11.5
$10,000-19,999 177 44.2 36.3 7.9
$20,000-34,999 221 37.0 29.0 8.0
$35,000+ 307 30.8 22.5 8.3
1: NHANES urban sample.
2: Hypertensive if mean systolic BP= >140 or mean diastolic BP= > 90 or
currently taking hypertensive medication.
3: Difference between clinical and self-reported hypertension.
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provider that they had HBP. These parameter estimates
were then applied (‘plug-in’ method) to the HEP sample
to obtain re-calibrated estimates of sensitivity and speci-
ficity for each HEP participant as indicated by Equations
(1) and (2) above. Self-reported HBP for each HEP par-
ticipant was also estimated. Finally, the probability of
clinically measured HBP was then obtained using both
Methods 1 and 2 (described above).
We then dichotomized these estimates using 0.5, 0.6,
0.7 and 0.8 as threshold values as indicated by Equations
(5) and (6) above. In Table 7 we present estimates of
sensitivity and specificity of the binary representation of
the predicted probability with respect to the available
measure of clinical HBP (Equations (7) and (8)) for each
of the threshold values. For both methods 1 and 2, the
greatest sensitivity and specificity are found for the
threshold value of 0.50 At this threshold level, the overall
final adjusted estimate of prevalence of HBP was 38.1%
(sensitivity= 0.90; specificity = 0.78) for Method 1 and
40.5% (sensitivity= 0.92; specificity = 0.79) for Method 2.
Both final adjusted estimates were considerably closer to
the clinically derived prevalence of 40.1% (Table 2) for the
HEP community sample, compared to the unadjusted self
report estimate of 29.7%.
Discussion
Findings reported here suggest that self-reported data
underestimate the prevalence of high blood pressure in
the NHANES urban sample by 8.1% and in the HEP
local community sample by 10.4%. These underestimates
are larger than those reflected in the full NHANEs
2001–2002 sample of 7.5%, suggesting that the degree of
underestimation of hypertension prevalence based on
self-reported data may be larger in urban compared to
national samples. Furthermore, prevalence of hyperten-
sion appears to be higher in the two community samples
used in this analysis (33.8% and 40.1% for the NHANES
urban and HEP samples respectively), compared to
the 30.4% reported for the NHANES 2001–2002 full
sample. These results suggest that the application of
Table 5 Sensitivity, specificity and agreement indicators for each determinant investigated (sex, educational level,
income level) (NHANES Urban Sample N=1114)
Sensitivity Specificity Accuracy Kappa
P(CH=1|SR= 1) P(CH=0|SR= 0) Overall agreement)
Full sample 0.92 0.86 0.88 0.77
Age
25-34 0.93 0.87 0.89 0.78
35-49 0.99 0.70 0.83 0.67
50+ 0.99 0.68 0.84 0.60
Gender
Females 0.94 0.89 0.90 0.75
Males
Marital Status
Current Married 0.91 0.86 0.88 0.76
Not Married 0.91 0.84 0.86 0.77
Race/ethnicity
Latino 0.99 0.88 0.90 0.77
Non-Hispanic White 0.92 0.86 0.87 0.74
Non-Hispanic Black 0.93 0.84 0.87 0.76
Education
<12 0.96 0.83 0.88 0.75
12 0.93 0.85 0.87 0.76
12+ 0.90 0.88 0.88 0.76
Annual Household Income
<$10,000 0.96 0.82 0.87 0.76
$10,000-19,999 0.93 0.89 0.90 0.76
$20,000-34,999 0.89 0.85 0.86 0.77
$35,000+ 0.90 0.89 0.90 0.77
Accuracy is the proportion of true results (both true positive and true negative). Refer to Additional file 1.
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national rates, or the use of corrections derived from
national samples, may not be appropriate to estimate
hypertension prevalence in some urban communities.
We found the highest levels of HBP, and the greatest
discrepancies between self-reported and clinically mea-
sured HBP, in the HEP community sample. This com-
munity is characterized by a higher proportion of
residents with lower socioeconomic status, and by a
greater proportion of Hispanic and non-Hispanic Black
participants compared to the NHANES urban sample.
The higher levels of HBP, and the greater discrepancy
between self-reported and clinically measured HBP in
this sample may reflect more restricted access to health
care providers compared to the NHANES urban or the
NHANES national sample.
Our finding are consistent with results reported in the
literature when considering large samples, simulations
or national sample such as the NHANES sample. We
extend these by showing the under-estimation of hyper-
tension for self-reported data can be even larger in small
communities. The range of the underreporting for the
HEP sample of 7.3% to 13.9% fell within the range of
0.2% to 27% reported in other studies that have assessed
the validity and concordance of self-reported data when
considering small samples like the one used in this
paper. The wide range of under-reporting complicates
the generalization of findings from one community to
another. Thus, developing a prediction model that will
allow re-calibration of self-reported data for small sam-
ples seems reasonable and appropriate.
Our second aim was to examine the feasibility of using
prediction models to correct for underestimates of
prevalence of HBP using self-reported data. The applica-
tion of prediction models derived from the NHANES
urban sample to data from the HEP community sample
resulted in re-adjusted estimates of sensitivity and speci-
ficity. These adjusted estimates were then used to obtain
improved estimates of the probability if hypertension
that more closely correspond to clinically measured
levels of HBP in this community. Final re-calibrated
Table 6 Coefficients of prediction models of clinical
hypertension stratified by self-report using NHANES
urban sample
Clinical HBP1
Self-reported=Yes Self-reported=NO
Estimate (StErr) Estimate (StErr)
Intercept −0.3(1.36) −2.52(0.6)
Age2 0.12(0.03) 0.04(0.01)
Gender
Females 0.41(0.64) −0.52(0.21)
Males (reference) 1 1
Marital Status
Married −0.36(0.61) 0.04(0.25)
Not Married (reference) 1 1
Race/ethnicity
Latino * −0.46(0.42)
White 0.03(0.84) −0.43(0.31)
Black (reference)
Education
<12 0.51(1.36) 0.02(0.27)
12 0.67(0.84) 0.2(0.29)
12 + (reference)
Annual Household Income
<$10,000 0.20(0.99) 0.53(0.37)
$10,000-19,999 −0.48(1.09) −0.04(0.33)
$20,000-34,999 −0.75(0.65) 0.4(0.51)
$35,000+ (reference)
1: Clinical measured hypertension is the outcome.
2: Continuous age was used in prediction models.
Table 7 Comparison of predicted and measured high blood pressure for different threshold values (HEP sample)
Threshold (p)3 Method 11 Method 22
Sensitivity Pr(CH=1|SR= 1) Specificity Pr(CH=0|SR= 0) Sensitivity Pr(CH=1|SR= 1) Specificity Pr(CH=0|SR= 0)
0.5 0.90 0.78 0.92 0.78
0.6 0.89 0.75 0.91 0.77
0.7 0.85 0.66 0.90 0.76
0.8 0.79 0.62 0.89 0.74
1: Method 1.
a) For individuals who reported never being told they had HBP (SR = 0), we estimate the probability of having clinically measured HBP using one minus the
specificity estimate described in Equation (1).
b) For individuals who reported having been told they had HBP (SR = 1), we estimate the probability of having clinically measured HBP using the sensitivity
estimate described in Equation (2).
2: Method 2.
a) Estimates of the probability of self-reported HBP within the HEP sample, using weighted logistic regression models adjusting for the same set of covariates
used to calculate sensitivity and specificity.
b )Estimate of the probability of clinically measured HBP as a weighted average of re-calibrated sensitivity and specificity.
3: Threshold values of the estimated probability of clinically measured HBP which were used to classify each individual into one of two groups, Clinical
Hypertensive or not.
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estimates of hypertension, 38.1% and 40.5% for the HEP
sample, using both Method 1 (Equations (1) and (2))
and Method 2 (Equations (3) and (4)) resulted in esti-
mates that were much closer to population prevalence of
hypertension, 40.1%. These findings suggest that predic-
tion models similar to those used here can be applied to
obtain more accurate estimates of hypertension preva-
lence in local communities.
In this case, we created and applied a prediction model
based on national metropolitan (as an approximation of
urban) data to a local multi-ethnic urban community.
Based on the findings reported here, we suggest that
prediction models can be used to adjust self-report HBP
data to obtain more accurate estimates of HBP preva-
lence by following the procedures described below:
1. Using NHANES 2001–2002 data similar to the
researcher’s data set, predict the probability of
clinical hypertension stratified by self-reported
hypertension, i.e., using SRi and Xi Apply the
coefficient estimates of the logistic models into the
researcher’s sample (in our case the HEP sample) to
re-calibrate sensitivity and specificity estimates using
Equations (1) and (2).
2. Estimate the probability of self-report HBP using
Equation (3) for each participant.
3. Estimate the probability of clinically measured HBP
using Equation (4) for each participant.
4. Using the threshold value of 0.50 classify each
respondent into one of two groups: has clinically
measures HBP or not.
Limitations
Like most studies, there are a number of limitations that
should be considered in interpreting the findings
reported here. The comparison between NHANES
2001–2002 urban sample and the HEP community sam-
ple is limited by a number of factors. There are import-
ant differences between the NHANES urban and the
HEP sample in racial and ethnic composition, income
and education, each of which are important correlates of
high blood pressure in the United States. While we have
adjusted for these factors in our models, it is feasible
that these differences in the structure of the samples
may have influenced the findings reported here.
Conclusions
Finding presented here reiterate the importance of
developing them means to handle self-reported data
developing disease specific and community specific
models. The accuracy of self-report of HBP prevalence
differs from the accuracy of self-report for other diseases
(citations) and varies across communities. Simple models
like the ones proposed in this paper are easy to
implement and can be a very important tool to re-
calibrate self-reported data to better estimate chronic
disease prevalence for local communities.
Despite the limitations described above, the findings
reported here suggest that the use of prediction models
may be useful in creating estimates of hypertension
prevalence based on self-report data. Differences were
larger in the Detroit based community sample, which
also had the highest rates of HBP (regardless of type of
measure) suggesting that reliance on self-report data
may disproportionately underestimate prevalence of
HBP in low to moderate income, racially and ethnically
diverse urban communities such as Detroit.
Our results indicate that reliance solely on measures
of agreement to determine validity of self-reported data
in small samples whose demographic characteristics dif-
fer from those of national samples may be conducive to
underestimation of hypertension prevalence. While a
number of studies using large national samples have
reported validity of self-reported data based on measures
of sensitivity and specicity [18,20-22], the findings
reported here suggest that in smaller, more localized
samples, the use of prediction models that account for
the mischaracterization of self-reported data jointly
with measures of agreement may result in more accurate
estimates of hypertension prevalence. The relatively
simple prediction models proposed here provided a re-
calibrated prevalence of hypertension estimate that more
closely corresponded to the clinical hypertensive preva-
lence for the Detroit sample to which it was applied in
this example.
The non-stratified prediction models used in this ex-
ample improved the accuracy of overall estimates of
prevalence of HBP derived from self-reported data,
which is much less costly to collect than clinically mea-
sured HBP. As a result, such prediction models offer a
low cost approach to improve prevalence estimates and
thus the ability to plan prevention and treatment efforts
to reduce high blood pressure and its negative health
effects. Given limited funds available for public health
surveillance, health promotion and treatment efforts,
prediction models that enable accurate estimates at
lower costs may allow limited funds to be shifted toward
health promotion and treatment efforts in high-risk
urban populations.
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